A Phase I Study to Evaluate the Safety, Tolerability, and PK of HLX43 in Advanced/Metastatic Solid Tumors
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jie Wang, Dr.
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cancer Hospital, Chinese Academy of Medical Sciences
Beijing, Beijing Municipality, China
- Xiangya Hospital Central South University
Changsha, Hu'nan, China
- Sendai Kousei Hospital
Sendai, Miyagi, Japan
- Kindai University Hospital
Sayama, Osaka, Japan
- Okayama University Hospital
Okayama, Japan
- Shizuoka Cancer Center
Shizuoka, Japan
- National Cancer Center Hospital
Tokyo, Japan
- Stanford University
Stanford, California, United States
- Georgetown University
Washington D.C., District of Columbia, United States
- Md Anderson Medical Center
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 24 Nov 2023
- Primary completion
- 30 Jun 2026
- Completion
- 30 Nov 2027
- Last update posted
- 29 May 2026
- Registered enrollment
- 367
- Registry id
- NCT06115642
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.